Methyl 4-(3-Chloro-4-fluorophenyl)-4-methyl-6-(morpholinomethyl)-2-thiazol-2-yl-1H-pyrimidine-5-carboxylate

ID: ALA4555377

PubChem CID: 155556898

Max Phase: Preclinical

Molecular Formula: C21H22ClFN4O3S

Molecular Weight: 464.95

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1(C)c1ccc(F)c(Cl)c1

Standard InChI:  InChI=1S/C21H22ClFN4O3S/c1-21(13-3-4-15(23)14(22)11-13)17(20(28)29-2)16(12-27-6-8-30-9-7-27)25-18(26-21)19-24-5-10-31-19/h3-5,10-11H,6-9,12H2,1-2H3,(H,25,26)

Standard InChI Key:  YENLKMPVUICIFW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    9.0745   -8.1211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5946   -8.7457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3041   -9.1502    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3041   -9.9713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5946  -10.3837    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8892   -9.9713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8892   -9.1502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1823   -8.7413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1823   -7.9264    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4777   -9.1473    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7708   -8.7383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1762  -10.3759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1762  -11.1907    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4698  -11.5965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4698  -12.4176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1734  -12.8329    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8841  -12.4194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8841  -11.5983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0094  -10.3759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7601  -10.0402    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.3062  -10.6470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8989  -11.3574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0993  -11.1899    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1187   -8.1211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9256   -8.2657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4456   -7.6300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1629   -6.8607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3601   -6.7273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8359   -7.3519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6871   -6.2328    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.2523   -7.7673    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  4  3  2  0
  5  4  1  0
  6  5  1  0
  7  6  2  0
  2  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
  6 12  1  0
 12 13  1  0
 13 14  1  0
 15 14  1  0
 16 15  1  0
 17 16  1  0
 18 17  1  0
 13 18  1  0
  4 19  1  0
 19 20  1  0
 21 20  1  0
 22 21  2  0
 23 22  1  0
 19 23  2  0
  2 24  1  0
 24 25  2  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 29 28  2  0
 24 29  1  0
 27 30  1  0
 26 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4555377

    ---

Associated Targets(non-human)

Hepatitis B virus (7925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 464.95Molecular Weight (Monoisotopic): 464.1085AlogP: 2.96#Rotatable Bonds: 5
Polar Surface Area: 76.05Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.65CX LogP: 2.70CX LogD: 2.70
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.69Np Likeness Score: -1.47

References

1. Qiu Z, Lin X, Zhou M, Liu Y, Zhu W, Chen W, Zhang W, Guo L, Liu H, Wu G, Huang M, Jiang M, Xu Z, Zhou Z, Qin N, Ren S, Qiu H, Zhong S, Zhang Y, Zhang Y, Wu X, Shi L, Shen F, Mao Y, Zhou X, Yang W, Wu JZ, Yang G, Mayweg AV, Shen HC, Tang G..  (2016)  Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors.,  59  (16): [PMID:27458651] [10.1021/acs.jmedchem.6b00879]

Source